Focus and Scope

Archive of Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice in a range of article types: Comment, Correspondence, News, Cancer and Society, Editorial, Article, Review, Policy Review, Personal View, Clinical Report, Clinical Picture and Case Report.

The journal publishes all aspects of medical, surgical, radiation and experimental oncology, cancer epidemiology, and prevention. Archive of Oncology covers resources on the mechanism, cause, and treatment of cancer including environmental and genetic risk factors, and cellular and molecular carcinogenesis.


Peer Review Process

Peer reviewers

Archive of Oncology uses double-blind review system. Each manuscript is reviewed by at least two reviewers. The reviewers act independently and they are not aware of each other’s identities. The reviewers are selected solely according to whether they have the relevant expertise for evaluating a manuscript. They must not be from the same institution as the author(s) of the manuscript, nor be their co-authors in the recent past. No suggestions of individual reviewers by the author(s) of the manuscript will be accepted.

The purpose of peer review is to assists the Editorial Board in making decision of whether to accept or reject a paper. The purpose is also to assist the author in improving papers.

Peer review process

Manuscripts are sent for review only if they pass the initial evaluation regarding their form and thematic scope. A special care is taken that the initial evaluation does not last more than necessary.

Under normal circumstances, the review process takes up to eight weeks. The total period from the submission of a manuscript until its publication takes an average of 70 days.

During the review process the Editor-in-Chief may require authors to provide additional information (including raw data) if they are necessary for the evaluation of the manuscript. These materials will be kept confidential and will not be used for any other purposes.

The entire review process takes place under the supervision of the Editor-in-Chief in an online environment, within the SCIndeks Assistant, a system based on the Open Journal System platform. The system also allows authors to track the entire process of reviewing the manuscript.

Resolving inconsistences

In the case that the authors have serious and reasonable objections to the reviews, the Editorial Board makes an assessment of whether a review is objective and whether it meets academic standards. If there is a doubt about the objectivity or quality of review, the Editor-in-Chief will assign additional reviewer(s).

Additional reviewers may also be assigned when reviewers’ decisions (accept or reject) are contrary to each other or otherwise substantially incompatible.

The final decision on the acceptance of the manuscript for publication rests solely with the Editor-in-Chief.

Open Access Policy

This journal provides immediate open access to all published content.


Oncology Institute of Vojvodina is a sole sponsor of the Archive of Oncology Journal

Sources of Support

Assignment of DOI (Digital Object Identifier) for the Journal is supported by Ministry of Education, Science and Technological Development of the Republic of Serbia.

Journal History

Archive of Oncology was founded in 1993 and is a successor of the Onkološki Arhiv journal.

Archive of Oncology is an Open Access journal. Contributions to journal shall be submitted in English language, with summaries in English language. Electronic Issues are available online: abstracts only (since 1997) and abstracts with full text (since 2000) at

Founder, owner and publisher of the Archive of Oncology Journal is Oncology Institute of Vojvodina. The journal is registered in the Intellectual Property Office, Serbia. Starting with year 2017 Archive of Oncology is published in electronic form only.

The journal follow Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and Committee on Publication Ethics (COPE) code of conduct for editors guidelines (COPE's guidelines).

Editorial Board

Editor-in-Chief: Dragana Četojević-Simin (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)

Associate Editors:
Duško Kozić (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Jasna Mihailović (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Jasna Trifunović (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Milanka Tatić (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Svetlana Popović-Petrović (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Zoran Radovanović (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Dragana Radovanović (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Tatjana Ivković-Kapicl (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Tihomir Dugandžija (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Silvija Lučić (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)
Nataša Prvulović-Bunović (Oncology Institute of Vojvodina, Sremska Kamenica, Serbia)